Cantor Fitzgerald Investment Advisors L.P. Has $468,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cantor Fitzgerald Investment Advisors L.P. cut its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 16.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,110 shares of the pharmacy operator’s stock after selling 9,660 shares during the period. Cantor Fitzgerald Investment Advisors L.P.’s holdings in Walgreens Boots Alliance were worth $468,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. State Street Corp grew its position in Walgreens Boots Alliance by 18.0% in the 3rd quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after purchasing an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock worth $98,284,000 after acquiring an additional 3,329,857 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Walgreens Boots Alliance by 12.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock valued at $68,046,000 after purchasing an additional 817,762 shares during the last quarter. Thompson Siegel & Walmsley LLC increased its stake in shares of Walgreens Boots Alliance by 15.5% in the third quarter. Thompson Siegel & Walmsley LLC now owns 6,955,880 shares of the pharmacy operator’s stock worth $62,325,000 after purchasing an additional 934,754 shares in the last quarter. Finally, FMR LLC raised its position in shares of Walgreens Boots Alliance by 2.5% in the third quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock valued at $29,200,000 after purchasing an additional 80,525 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $10.12 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The business’s 50 day moving average is $10.20 and its 200 day moving average is $9.83. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $22.96.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.66 earnings per share. Equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analyst Ratings Changes

WBA has been the topic of a number of analyst reports. Royal Bank of Canada upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Barclays boosted their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Bank of America lifted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Morgan Stanley decreased their price objective on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. Finally, Jefferies Financial Group decreased their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Four research analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $13.19.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.